CT Number Change As a Supplemental Prognostic Surrogate for Assessing Radiation Treatment Response of Lung Tumor

C. Yang,E. Dalah,A. Tai,J. Zhang,E. M. Gore,C. Johnstone,A. Li

DOI: https://doi.org/10.1016/j.ijrobp.2015.07.024

2015-01-01

Abstract:To investigate whether the CT number (CTN) change observed during image guided radiation therapy (IGRT) can be used as a supplemental prognostic surrogate for lung tumor response by analyzing the correlations between the CTN change, tumor volume change, and standard uptake value (SUV) change from pre and posttreatment PET-CT images. Pre and post-RT FDG-PET and the daily diagnostic-quality CTs acquired during IGRT using an in-room CT for 16 lung cancer patients were analyzed. Patients with ages ranging from 35 to 73 years old were irradiated with either concurrent or sequential chemotherapy. The treatment targets, including primary tumors and involved nodal regions, were treated with 60 Gy in 30 fractions or 45 Gy in 15 fractions. Target contours from the planning CT, which were drawn based on the pre-RT PET-CT and/or anatomy features, were transferred to daily CTs using a deformable image registration tool. Transferred target contours were reviewed and edited, if necessary. Mean CTN was calculated from the voxel-based CTNs inside the target contour. For a given target, the correlations among changes of mean CTN and target volume from the planning CT to daily CTs, and the change of maximum SUV before and after RT were analyzed. Substantial reductions in mean lung tumor CTN, as much as 46 Hounsfield units (HU), were observed during the RT delivery for patients with partial and complete responses according to RECIST analysis. For cases with stable and progressive disease, the CTN was stable (±4 HU), or increased by as much as 8 HU. When there is a substantial CTN reduction, as in patients with partial or complete response to the treatment, the change is visually discernable from one day to the next, suggesting that lung tumor CTN may be used as an early prognostic indicator. For the 16 patients analyzed, when cutoff value of CTN reduction is set to 7 HU, the confidence interval between lung tumor CTN reduction and tumor partial response is 100%. The confidence interval between lung tumor CTN reduction and SUV reduction is also 100%. The confidence interval of predicting tumor partial response is higher for tumor CTN reduction (100% for cutoff value) than for SUV reduction (87.5% for cutoff value). The lung tumor CTN change correlates with the changes in the tumor size and SUV using RECIST criteria, indicating that lung tumor CTN may be a supplemental surrogate for assessing tumor response. For patients treated with daily CT guided RT, lung tumor CTN change can be observed in the early phase of RT without additional cost, and thus may be used for early prediction of treatment response.